Experts from Cerner Enviza provide a high level overview on utilizing Electronic Health Record (EHR) clinical data to support Real World Evidence (RWE) studies.

This presentation discusses the value of using EHR data as well as linking claims and EHR data to more effectively achieve your outcomes research study objectives. The speakers present each of these datasets and the key variables that distinguish them from other research datasets, thus providing a 360 view of the patient (ambulatory, in-patient, ER). Prospective longitudinal research can also be conducted directly from the EHR. Two case studies are also presented to better illustrate this value of these datasets.

Key Topics Include:

  • Understanding the value of EHR data for performing RWE studies
  • The unique characteristics of Cerner Enviza EHR Data in the context of support studies
  • How linked EHR and claims can support studies
  • How primary data collection efforts can be linked with EHR (or claims)
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.

Production Partner

Cerner Enviza

By combining decades of innovation, life sciences knowledge and collaborative research, Cerner Enviza provides data-driven solutions and expertise that helps bring remarkable clarity to life sciences’ and healthcare’s most important decisions.

Related Content

How to assess the quality of AI output when structuring unstructured medical data

How to assess the quality of AI output when structuring unstructured medical data

Looking to empower your organizations with high quality patient data? Human abstraction has long been considered the gold standard for extracting high quality information from EHR data. With the rise of NLP, large language models, and machine learning, the question becomes: how should we evaluate these new technologies against the traditional abstraction methods?
Pairing quality genomic data with longitudinal patient records

Pairing quality genomic data with longitudinal patient records

Sure, you've used claims and electronic health records in your research. But have you ever explored linking phenotypic and genomic or other -omic data to assess the full view of the patient journey? In this fireside chat with experts from Optum Life Sciences and DNAnexus, learn how longitudinal, linked data sets enable life sciences companies to discover new druggable targets, identify potential treatment populations, understand the genetic testing landscape and barriers to access, and more.